NCT06103981 is a clinical trial of Acute Liver Injury in Acute Liver Injury, sponsored by Assiut University.

Who is sponsoring NCT06103981?

NCT06103981 is sponsored by Assiut University.

What drugs are being tested in NCT06103981?

Interventions in NCT06103981: Acute Liver Injury.

What condition does NCT06103981 study?

NCT06103981 studies Acute Liver Injury, Pneumonia.

Is NCT06103981 still recruiting?

NCT06103981 is currently status unknown. Last updated 27 October 2023.

Last reviewed 2023-10-27 · How we verify

NCT06103981

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Liver Injury in Patients With Pneumonia

Status unknown Last updated 27 October 2023

What this trial tests

trial testing Acute Liver Injury in Acute Liver Injury in 176 participants. Status unknown.

Timeline

1 December 2023

Primary endpoint
10 January 2025

10 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	176
Start date	1 December 2023
Primary completion	10 January 2025
Estimated completion	10 March 2025
Sites	1 location across Egypt

Drugs / interventions tested

Acute Liver Injury

Conditions studied

Acute Liver Injury — all drugs for Acute Liver Injury →
Pneumonia — all drugs for Pneumonia →

Sponsor

Assiut University

Who can join

Adults 18 to 68, any sex, with Acute Liver Injury or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute liver injury (ALI) is defined as an acute derangement in liver function tests associated with liver-related coagulopathy, in the absence of underlying chronic liver disease. A subset progress to acute liver failure ,Acute liver failure represent a more severe liver injury results in hepatic encephalopathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Liver Injury

Currently open trials in the same condition.

NCT02833064 — Biomarkers in Liver Failure · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06103981 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 27 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06103981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing